084650 — Labgenomics Co Income Statement
0.000.00%
Last trade - 00:00- KR₩160bn
- KR₩159bn
- KR₩86bn
- 71
- 33
- 27
- 38
Annual income statement for Labgenomics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 119,478 | 202,407 | 144,773 | 71,076 | 85,898 |
| Cost of Revenue | |||||
| Gross Profit | 71,750 | 125,411 | 96,767 | 30,359 | 31,408 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 66,210 | 97,944 | 78,567 | 77,999 | 107,532 |
| Operating Profit | 53,268 | 104,463 | 66,206 | -6,923 | -21,633 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 51,822 | 109,132 | 63,393 | -7,133 | -25,952 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 42,764 | 83,855 | 47,926 | -5,291 | -23,691 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 42,766 | 83,855 | 48,397 | -4,674 | -23,796 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 42,766 | 83,855 | 48,397 | -4,674 | -23,796 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 670 | 1,246 | 715 | -75.9 | -290 |
| Dividends per Share |